{
    "2019-07-31": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat",
                "features": {
                    "keywords": [
                        "Ligand",
                        "LGND",
                        "Stock Down",
                        "Q2 Earnings",
                        "Sales Beat"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised",
                "features": {
                    "keywords": [
                        "Gilead",
                        "GILD",
                        "Q2 Earnings",
                        "Sales Beat",
                        "Sales Guidance Raised"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}